These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1808109)

  • 21. Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40.
    Berthezène Y; Vexler V; Price DC; Wisner-Dupon J; Moseley ME; Aicher KP; Brasch RC
    Invest Radiol; 1992 May; 27(5):346-51. PubMed ID: 1582816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadopentetate dimeglumine as a marker of renal function. Magnetic resonance imaging to glomerular filtration rates.
    Frank JA; Choyke PL; Austin HA; Girton ME; Weiss G
    Invest Radiol; 1991 Nov; 26 Suppl 1():S134-6; discussion S137-8. PubMed ID: 1808110
    [No Abstract]   [Full Text] [Related]  

  • 23. Can gadolinium be safely given in renal failure?
    Weissleder R
    AJR Am J Roentgenol; 1996 Jul; 167(1):278-9. PubMed ID: 8659405
    [No Abstract]   [Full Text] [Related]  

  • 24. New magnetic resonance imaging contrast agents for infarct imaging based on phosphonate derivatives of Gd-DTPA.
    Adzamli IK; Blau M; Pfeffer MA; Davis MA
    Invest Radiol; 1991 Nov; 26 Suppl 1():S242-4; discussion S245-7. PubMed ID: 1808139
    [No Abstract]   [Full Text] [Related]  

  • 25. Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA.
    Kucharczyk J; Asgari H; Mintorovitch J; Vexler Z; Moseley M; Watson A; Rocklage S
    Invest Radiol; 1991 Nov; 26 Suppl 1():S250-2; discussion S253-4. PubMed ID: 1808141
    [No Abstract]   [Full Text] [Related]  

  • 26. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors.
    Niemi P; Kurki T; Lundbom N; Kormano M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140
    [No Abstract]   [Full Text] [Related]  

  • 27. MRI of blood-brain barrier permeability in astrocytic gliomas: application of small and large molecular weight contrast media.
    Schmiedl UP; Kenney J; Maravilla KR
    Magn Reson Med; 1991 Dec; 22(2):288-92. PubMed ID: 1812359
    [No Abstract]   [Full Text] [Related]  

  • 28. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging.
    Schmiedl U; Brasch RC; Ogan MD; Moseley ME
    Acta Radiol Suppl; 1990; 374():99-102. PubMed ID: 1966977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organ and tissue specific contrast media in magnetic resonance imaging.
    Niemi P
    Acta Radiol Suppl; 1991; 377():56-7. PubMed ID: 1666259
    [No Abstract]   [Full Text] [Related]  

  • 30. Gadolinium-DTPA enhanced MRI in neonatal osteomyelitis of the cervical spine.
    Martijn A; van der Vliet AM; van Waarde WM; van Aalderen WM
    Br J Radiol; 1992 Aug; 65(776):720-2. PubMed ID: 1393402
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
    Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
    Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine.
    Vexler VS; Clément O; Brasch RC
    Invest Radiol; 1994 Jun; 29 Suppl 2():S62-4. PubMed ID: 7928273
    [No Abstract]   [Full Text] [Related]  

  • 33. Gd-DTPA as a contrast agent in CT.
    Bloem JL; Wondergem J
    Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced magnetic resonance imaging with intracellular contrast agents--a new way of monitoring hepatic reperfusion injury?
    Bremer C; Spiegel HU; Allkemper T; Reimer P; Rummeny EJ; Peters PE
    Transplant Proc; 1995 Oct; 27(5):2849-51. PubMed ID: 7482941
    [No Abstract]   [Full Text] [Related]  

  • 35. Aerosolized gadolinium-DTPA enhances the magnetic resonance signal of extravascular lung water.
    Montgomery AB; Paajanen H; Brasch RC; Murray JF
    Invest Radiol; 1987 May; 22(5):377-81. PubMed ID: 3597005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gadolinium-DTPA: a new contrast agent.
    Niendorf HP
    Bristol Med Chir J; 1988 May; 103(2):34. PubMed ID: 3219630
    [No Abstract]   [Full Text] [Related]  

  • 37. [Importance of contrast medium administration in determining the age of traumatic renal hemorrhage by NMR tomography--experimental results].
    Uhlenbrock D; Rühl G; Beyer HK
    Rofo; 1988 Feb; 148(2):161-4. PubMed ID: 2831578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience using gadolinium-DTPA in cardiovascular MRI.
    Nishimura T; Yamada N; Haze K; Nagata S
    Magn Reson Med; 1991 Dec; 22(2):354-7; discussion 364-5. PubMed ID: 1812370
    [No Abstract]   [Full Text] [Related]  

  • 39. Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide.
    Chang CA
    Invest Radiol; 1993 Mar; 28 Suppl 1():S21-7. PubMed ID: 8486500
    [No Abstract]   [Full Text] [Related]  

  • 40. [The value of gadolinium-DTPA in the study of the urinary bladder].
    Beyer HK; Blümm R; Hötzinger H
    Rontgenpraxis; 1988 Feb; 41(2):57-64. PubMed ID: 3363435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.